Based on the FY22 figures the Prescribed Capital Amount was $855.5million. The target PCA multiple range is 1.4 to 1.6x. So taking the upper end of that . 1.6 x 855.5million = $1368.8million. FY22 HLI had $1888.4milion of regulatory capital under AASB17 standards. ie. at FY22 (under AASB17 rules) HLI had $519.6million of capital to return to reach the top end of target range. To put that in context the balance sheet at FY22 showed $1205.7million of net assets under AASB17 . ie. HLI has to return 43% of it's net assets to reach top end of target PCA multiple range.
Me Guessing that PCA multiple is now nearer 2.4x PCA would imply something in the range $684.4million to $855million needs to be returned . or 57% to 71% of balance sheet net assets to reach 1.4 to 1.6x PCA.
The company has not changed it's guidance of reaching target PCA multiple next year. The question remains: how is the company going to return this much capital in an ever shortening window of time. I guess at the end of the day they can just do a massive special dividend or capital return .
- Forums
- ASX - By Stock
- excess reg capital
Based on the FY22 figures the Prescribed Capital Amount was...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HLI (ASX) to my watchlist
|
|||||
Last
$3.86 |
Change
0.050(1.31%) |
Mkt cap ! $1.118B |
Open | High | Low | Value | Volume |
$3.85 | $3.86 | $3.79 | $2.238M | 584.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2868 | $3.85 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.86 | 8921 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1259 | 3.850 |
2 | 5000 | 3.830 |
1 | 400 | 3.820 |
1 | 1500 | 3.810 |
1 | 2630 | 3.800 |
Price($) | Vol. | No. |
---|---|---|
3.880 | 10447 | 2 |
3.930 | 5090 | 1 |
3.940 | 6000 | 2 |
3.950 | 2019 | 2 |
3.960 | 1000 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
HLI (ASX) Chart |